Your browser doesn't support javascript.
loading
RNA Trans-Splicing Modulation via Antisense Molecule Interference.
Liemberger, Bernadette; Piñón Hofbauer, Josefina; Wally, Verena; Arzt, Claudia; Hainzl, Stefan; Kocher, Thomas; Murauer, Eva M; Bauer, Johann W; Reichelt, Julia; Koller, Ulrich.
Afiliação
  • Liemberger B; EB House Austria, Research Program for Molecular Therapy of Genodermatoses, Department of Dermatology, University Hospital of the Paracelsus Medical University, 5020 Salzburg, Austria. b.liemberger@salk.at.
  • Piñón Hofbauer J; EB House Austria, Research Program for Molecular Therapy of Genodermatoses, Department of Dermatology, University Hospital of the Paracelsus Medical University, 5020 Salzburg, Austria. j.d.pinon@salk.at.
  • Wally V; EB House Austria, Research Program for Molecular Therapy of Genodermatoses, Department of Dermatology, University Hospital of the Paracelsus Medical University, 5020 Salzburg, Austria. v.wally@salk.at.
  • Arzt C; Laboratory for Immunological and Molecular Cancer Research, Department of Internal Medicine III with Hematology, Medical Oncology, Hemostaseology, Infectious Diseases, Rheumatology, Oncologic Center, Paracelsus Medical University, 5020 Salzburg, Austria. c.arzt@salk.at.
  • Hainzl S; EB House Austria, Research Program for Molecular Therapy of Genodermatoses, Department of Dermatology, University Hospital of the Paracelsus Medical University, 5020 Salzburg, Austria. s.hainzl@salk.at.
  • Kocher T; EB House Austria, Research Program for Molecular Therapy of Genodermatoses, Department of Dermatology, University Hospital of the Paracelsus Medical University, 5020 Salzburg, Austria. t.kocher@salk.at.
  • Murauer EM; EB House Austria, Research Program for Molecular Therapy of Genodermatoses, Department of Dermatology, University Hospital of the Paracelsus Medical University, 5020 Salzburg, Austria. e.murauer@salk.at.
  • Bauer JW; Department of Dermatology, University Hospital of the Paracelsus Medical University, 5020 Salzburg, Austria. jo.bauer@salk.at.
  • Reichelt J; EB House Austria, Research Program for Molecular Therapy of Genodermatoses, Department of Dermatology, University Hospital of the Paracelsus Medical University, 5020 Salzburg, Austria. j.reichelt@salk.at.
  • Koller U; EB House Austria, Research Program for Molecular Therapy of Genodermatoses, Department of Dermatology, University Hospital of the Paracelsus Medical University, 5020 Salzburg, Austria. u.koller@salk.at.
Int J Mol Sci ; 19(3)2018 Mar 07.
Article em En | MEDLINE | ID: mdl-29518954
ABSTRACT
In recent years, RNA trans-splicing has emerged as a suitable RNA editing tool for the specific replacement of mutated gene regions at the pre-mRNA level. Although the technology has been successfully applied for the restoration of protein function in various genetic diseases, a higher trans-splicing efficiency is still desired to facilitate its clinical application. Here, we describe a modified, easily applicable, fluorescence-based screening system for the generation and analysis of antisense molecules specifically capable of improving the RNA reprogramming efficiency of a selected KRT14-specific RNA trans-splicing molecule. Using this screening procedure, we identified several antisense RNAs and short rationally designed oligonucleotides, which are able to increase the trans-splicing efficiency. Thus, we assume that besides the RNA trans-splicing molecule, short antisense molecules can act as splicing modulators, thereby increasing the trans-splicing efficiency to a level that may be sufficient to overcome the effects of certain genetic predispositions, particularly those associated with dominantly inherited diseases.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Splicing de RNA / Regulação da Expressão Gênica / Oligonucleotídeos Antissenso / Trans-Splicing / Interferência de RNA Limite: Humans Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Splicing de RNA / Regulação da Expressão Gênica / Oligonucleotídeos Antissenso / Trans-Splicing / Interferência de RNA Limite: Humans Idioma: En Ano de publicação: 2018 Tipo de documento: Article